Artificial Intelligence

3 February, 2026

They manage to completely eliminate pancreatic tumors in mice without the appearance of resistance.

We share the latest milestone from the Experimental Oncology Group at the CNIO, which has managed to eliminate pancreatic tumors in animal models using a triple combination therapy without generating resistance.
14 July 2025

Uro-Oncogu(AI)s: artificial intelligence to resolve clinical questions in real time

This project aims to improve clinical decisions based on accurate, evidence-based responses in urology. It was developed over a 12-month period, under the supervision of 70 specialists using a multidisciplinary approach and supported by technological support from the Aragón Health Research Institute (IIS Aragón) and the Aragón Engineering Research Institute (I3A).
November 28, 2024

Registration is now open for the AI4HealthyAging project event, in which the IIS Aragón is participating

On December 10, the AI4HealthyAging project event will be held in Zaragoza. It is being carried out jointly by 15 organizations, including the IIS Aragón, and is aimed at early detection of diseases derived from aging through Artificial Intelligence.
November 5, 2024

DIVE Medical helps diagnose visual and neurocognitive problems in childhood

The company, which has specialists in ophthalmology and optometry from the IIS Aragón and the IACS, uses technology based on artificial intelligence to objectively explore vision in any patient through gaze tracking.
October 9, 2024

Nobel Prize in Physics 2024 for two pioneers in artificial neural networks

The Royal Swedish Academy of Sciences has awarded researchers John Hopfield, from Princeton University (USA), and Geoffrey Hinton, from the University of Toronto (Canada), for their discoveries and inventions that enable machine learning with artificial neural networks.
September 4, 2023

A pioneering study discovers that brain tumors 'hack' the communication between neurons

The researchers, from the CSIC and the CNIO, propose that cognitive loss in patients with brain metastasis may be due to the 'interferences' that cancer creates in neuronal circuits.